State Administration of Taxation: invoices for illegal use of more than 10000 pharmaceutical medical units

Source: legal network, July 23, 2013, learned from the State Administration of Taxation on July 22 that in the special rectification work jointly carried out by the Bureau, the Ministry of health and other seven units, 30000 drug and medical device production and operation units and profit-making medical institutions were inspected, 11000 enterprises were found to have illegal use of invoices, involving 35.2 illegal invoices RMB 2.52 billion for tax payment and fine Meanwhile, 34 cases of improper purchase and sale of medicine were investigated and dealt with It is understood that the special rectification work started in September last year has lasted for nine months, and seven departments have comprehensively inspected the use of invoices of units engaged in the production and operation of drugs and medical devices, public hospitals above the third level and profit-making medical institutions nationwide The work is led by the State Administration of Taxation and the Ministry of health, with the participation of the State Council Office of rectifying industry irregularities, the Ministry of supervision, the Ministry of public security, the State Administration for Industry and Commerce and the State Food and drug administration By the end of May this year, 6599 medical institutions, including more than 1700 public hospitals, had been checked and 14.98 million invoices had been collected, including 9.21 million invoices with a single amount of more than 10000 yuan On this basis, the production and operation units of drugs and medical devices and profit-making medical institutions shall be inspected According to the relevant person in charge of the Inspection Bureau of the State Administration of Taxation, the special rectification work adopts the method of "first checking the hospital, then checking the suppliers", focusing on the invoice inspection, by severely cracking down on the illegal acts of invoices in the field of pharmaceutical purchase and sale, blocking the grey interest chain of the pharmaceutical and health industry, and assisting the pharmaceutical management department to solve the prominent problems of "expensive medical treatment" reflected by the masses.